PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

General OA media and info, page-413

  1. 9,847 Posts.
    lightbulb Created with Sketch. 1262
    Yep he has been very consistent with this message about lower dosages having less efficacy

    Most of the market seems to have missed the key implications - including me!

    Refer to 23min mark - also gives good recap of FDA strict protocols and reasoning for staged approach

    https://www.youtube.com/watch?v=VDVI6QwXEX4


    p.s. Thought John Hester's prompting PR at end was perhaps the highlight. I've seen introverts with a stutter do more compelling Toast Master ice breakers than PR




 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.